USD 2.1
(-8.3%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -11.37 Million | -7.4 Million | -1.58 Million | -404.69 Thousand | -790.03 Thousand |
Net Income | -15.42 Million | -8.22 Million | -24.38 Million | -1.14 Million | -972.81 Thousand |
Depreciation & Amortization | 5468.00 | 2135.00 | 2468.00 | 2321.00 | 1082.00 |
Deferred income taxes | -2.43 Million | - | 22.84 Million | - | - |
Stock-based compensation | 2.56 Million | 624.06 Thousand | 218.98 Thousand | - | - |
Change in working capital | 1.65 Million | 195.2 Thousand | -391.03 Thousand | 165.84 Thousand | 181.69 Thousand |
Other non-cash items | 2.26 Million | 100 Thousand | 118.15 Thousand | 575 Thousand | -84.49 Thousand |
Investing Cash Flow | -52.08 Thousand | - | -802.00 | - | -7308.00 |
Investments in PPE | -52.08 Thousand | - | -802.00 | - | -7308.00 |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | -52.08 Thousand | - | -802.00 | - | - |
Financing Cash Flow | 15.46 Million | 3.23 Million | 18.84 Million | - | 1.05 Million |
Debt repayment | - | -50 Thousand | -200 Thousand | - | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | -99.96 Thousand | - | - | - |
Common Stock Issuance | 15.69 Million | 2.91 Million | 18.64 Million | - | - |
Other Financing Activities | -234.61 Thousand | 468.27 Thousand | 400 Thousand | - | 1.05 Million |
Accounts receivables | -893.4 Thousand | -236.38 Thousand | 97.66 Thousand | 58.49 Thousand | -36.29 Thousand |
Accounts payables | 2.43 Million | 1.13 Million | -106.06 Thousand | -3830.00 | 122.95 Thousand |
Inventory | - | 236.38 Thousand | -97.66 Thousand | -58.49 Thousand | 36.29 Thousand |
Other working capital | 111.84 Thousand | -936.53 Thousand | -284.97 Thousand | 169.67 Thousand | 58.74 Thousand |
Cash at beginning of period | 13.43 Million | 17.64 Million | 391.08 Thousand | 734.01 Thousand | 462.32 Thousand |
Cash at end of period | 17.5 Million | 13.43 Million | 17.64 Million | 391.08 Thousand | 734.01 Thousand |
Capital Expenditure | -52.08 Thousand | - | -802.00 | - | -7308.00 |
Effect of forex changes on cash | 33.09 Thousand | -31.52 Thousand | -5433.00 | 61.76 Thousand | 19.02 Thousand |
Net cash flow / Change in cash | 4.07 Million | -4.2 Million | 17.25 Million | -342.92 Thousand | 271.68 Thousand |
Free Cash Flow | -11.42 Million | -7.4 Million | -1.59 Million | -404.69 Thousand | -797.34 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -4.4 Million | -5.33 Million | -5.08 Million | -15.42 Million | -4.34 Million | -3.59 Million |
Depreciation & Amortization | 24.29 Thousand | 23.85 Thousand | 3076.00 | 5468.00 | 1381.00 | 506.00 |
Deferred income taxes | - | - | -668.66 Thousand | -2.43 Million | -605.11 Thousand | 535.76 Thousand |
Stock-based compensation | 637.85 Thousand | 943.26 Thousand | 1.05 Million | 2.56 Million | 737.32 Thousand | 447.65 Thousand |
Change in working capital | -1.51 Million | 537.1 Thousand | 1.42 Million | 1.65 Million | 518.54 Thousand | -365.29 Thousand |
Other non-cash items | -1.53 Million | 941.12 Thousand | 602.8 Thousand | 2.26 Million | 605.11 Thousand | -535.76 Thousand |
Investing Cash Flow | -97.07 Thousand | -301.91 Thousand | -13.17 Thousand | -52.08 Thousand | -38.91 Thousand | - |
Investments in PPE | -97.07 Thousand | -301.91 Thousand | -13.17 Thousand | -52.08 Thousand | -38.91 Thousand | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -52.08 Thousand | -52.08 Thousand | - | - |
Financing Cash Flow | - | 15.94 Million | 586.69 Thousand | 15.46 Million | 10.06 Million | 4.69 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 15.94 Million | 821.3 Thousand | 15.69 Million | 10.12 Million | 4.7 Million |
Other Financing Activities | - | 2489.00 | -234.61 Thousand | -234.61 Thousand | -58.8 Thousand | -15.81 Thousand |
Accounts receivables | 96.25 Thousand | -911.54 Thousand | -465.92 Thousand | -893.4 Thousand | -380.23 Thousand | 24.94 Thousand |
Accounts payables | -1.8 Million | 1.92 Million | 854.21 Thousand | 2.43 Million | 451.95 Thousand | 937.48 Thousand |
Inventory | - | - | -503.08 Thousand | - | 380.23 Thousand | -24.94 Thousand |
Other working capital | -1.6 Million | 1.44 Million | 1.03 Million | 111.84 Thousand | 66.59 Thousand | -1.3 Million |
Cash at beginning of period | 29.31 Million | 17.5 Million | 19.58 Million | 13.43 Million | 12.65 Million | 11.46 Million |
Cash at end of period | 23.97 Million | 29.31 Million | 17.5 Million | 17.5 Million | 19.58 Million | 12.65 Million |
Capital Expenditure | -97.07 Thousand | -301.91 Thousand | -13.17 Thousand | -52.08 Thousand | -38.91 Thousand | - |
Effect of forex changes on cash | 8910.00 | -10.36 Thousand | 31.28 Thousand | 33.09 Thousand | -11.77 Thousand | 14.13 Thousand |
Net cash flow / Change in cash | -5.34 Million | 11.8 Million | -2.07 Million | 4.07 Million | 6.92 Million | 1.19 Million |
Free Cash Flow | -5.35 Million | -4.12 Million | -2.69 Million | -11.42 Million | -3.12 Million | -3.51 Million |
ZODIAC
THEMISMED
BNL
4215
WKPPF
SEB